Meet the Speaker!

Daniel Morgenstern is a Staff Oncologist at Hospital for Sick Children, Toronto and Associate Professor at the University of Toronto. He originally trained and worked in the UK and moved to SickKids, Toronto in 2016 as Director of the New Agent and Innovative Therapy (NAIT) and Therapeutic mIBG Programs, and co-lead of the neuroblastoma service. He is also Medical Director of the Oncology/BMT Clinical Trials Support Unit. Dr Morgenstern’s clinical activities are focussed on neuroblastoma and solid tumour patients participating in early phase clinical trials. His research interests are in early phase trials and, in particular, the use of immune checkpoint inhibitors in paediatric cancers and the development of precision medicine approaches for paediatric solid tumours.

Webinar Objectives

We will discuss clinical trials in the context of paediatric oncology, including how international collaborative clinical trials have led to dramatic improvements in outcome for childhood cancers; how participation in clinical trials is integrated into routine clinical care within oncology; challenges with drug development in paediatric oncology and some potential solutions; a discussion about pathways for obtaining innovative therapies for patients and some of the challenges around participating in early phase trials in the context of incurable cancer.